Etretinate
Generic Name: etretinate
Manufactured by ROCHE. Dosage form: CAPSULE. Route: ORAL. Active ingredients: ETRETINATE (25MG). Application: NDA019369.
Overview
Manufactured by ROCHE. Dosage form: CAPSULE. Route: ORAL. Active ingredients: ETRETINATE (25MG). Application: NDA019369.
Dosage
Available as capsule for oral use.
Related Medications
Zanubrutinib
zanubrutinib
Kinase Inhibitor [EPC]
11 DESCRIPTION BRUKINSA (zanubrutinib) is a kinase inhibitor. The empirical formula of zanubrutinib is C 27 H 29 N 5 O 3 and the chemical name is ( S )-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5- a ]pyrimidine-3-carboxamide. Zanubrutinib is a white to off-white powder, with a pH of 7.8 in saturated solution. The aqueous solubility of zanubrutinib is pH dependent, from very slightly soluble to practically insoluble.
Titanium Dioxide, Octinoxate, Octisalate, Avobenzone
titanium dioxide, octinoxate, octisalate, avobenzone
Sunscreen
Zirconium Muriaticum
zirconium muriaticum
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.